All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Modulation of cell division of normal and cancer cells by cyclin-dependent kinase inhibitors

Public support

  • Provider

    Czech Science Foundation

  • Programme

    Standard projects

  • Call for proposals

    Standardní projekty 11 (SGA02008GA-ST)

  • Main participants

  • Contest type

    VS - Public tender

  • Contract ID

    301-08-1649

Alternative language

  • Project name in Czech

    Modulace buněčného dělení normálních a nádorových buněk inhibitory cyklin-dependentních kinas

  • Annotation in Czech

    Cyclin-dependentní kinasy (cdk) jsou kritickými regulátory buněčného cyklu a transkripce. Nalezení olomoucinu jako prvního účinného inhibitoru cdk přinesl logicky vývoj nové generace protinádorových látek na antimitotickém  základě, např. roskovitinu, olo

Scientific branches

  • R&D category

    ZV - Basic research

  • CEP classification - main branch

    FD - Oncology and haematology

  • CEP - secondary branch

    CE - Biochemistry

  • CEP - another secondary branch

    EB - Genetics and molecular biology

  • OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)

    10603 - Genetics and heredity (medical genetics to be 3)<br>10604 - Reproductive biology (medical aspects to be 3)<br>10605 - Developmental biology<br>10608 - Biochemistry and molecular biology<br>10609 - Biochemical research methods<br>30101 - Human genetics<br>30204 - Oncology<br>30205 - Hematology

Completed project evaluation

  • Provider evaluation

    V - Vynikající výsledky projektu (s mezinárodním významem atd.)

  • Project results evaluation

    Project provided new inhibitors of cyclin-dependent kinases as well as insight into the structure-activity relation of these inhibitors. It also suggested new therapeutical use for these drugs, especially for inhibitors of CDK9. Thus, this project has also implication for development of clinically relevant drugs. A vast number of papers in impacted journals underlies the success of investigators.

Solution timeline

  • Realization period - beginning

    Jan 1, 2008

  • Realization period - end

    Dec 31, 2012

  • Project status

    U - Finished project

  • Latest support payment

    Apr 1, 2012

Data delivery to CEP

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

  • Data delivery code

    CEP13-GA0-GA-U/02:3

  • Data delivery date

    May 17, 2016

Finance

  • Total approved costs

    6,985 thou. CZK

  • Public financial support

    6,985 thou. CZK

  • Other public sources

    0 thou. CZK

  • Non public and foreign sources

    0 thou. CZK